Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Long-Term Debt, Maturity, Year Five

2.8 / 5 stars · 68/120 Roast Me

Lantheus Holdings, Inc. Long-Term Debt, Maturity, Year Five

Lantheus Holdings, Inc. (LNTH) had Long-Term Debt, Maturity, Year Five of $0 as of 2023-12-31, per its 10-K filed 2024-02-22.

Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2024-02-22

  • 2023-12-31: Long-Term Debt, Maturity, Year Five $0.00.
  • 2022-12-31: Long-Term Debt, Maturity, Year Five $575.00M.
  • 2020-03-31: Long-Term Debt, Maturity, Year Five $148.75M.
  • 2019-12-31: Long-Term Debt, Maturity, Year Five $148.75M.
Period endLong-Term Debt, Maturity, Year Five
2023-12-31$0.00
10-K · filed 2024-02-22
2022-12-31$575.00M
10-K · filed 2023-02-23
2020-03-31$148.75M
10-Q · filed 2020-04-30
2019-12-31$148.75M
10-K · filed 2020-02-25
2019-09-30$15.00M
10-Q · filed 2019-10-31
2019-06-30$15.00M
10-Q · filed 2019-07-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B